ABOUT THE CLINICAL GUIDELINES PROGRAM

ABOUT THE CLINICAL GUIDELINES PROGRAM

About the AIDS Institute Clinical Guidelines Program

Introduction: The Clinical Guidelines Program is a collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute (AI), Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases. 

History: The NYSDOH AIDS Institute Guidelines Program began in the 1980’s in response to the clinical management challenges of HIV/AIDS. Since then, it has continuously addressed the HIV care and prevention needs of clinicians, supportive service providers, and consumers in New York State. In recent years, the AIDS Institute expanded its mission to support the efforts of those involved in preventing HIV and to those who provide medical care and services to LGBTQ people, and to people living with HCV, STIs, and substance use. The guidelines program has evolved to address those expanding priorities as well.

Mission: The mission of the AIDS Institute Guidelines program is to develop and disseminate practical, evidence-based clinical guidelines that promote quality medical care for people in New York who are living with and/or are at risk of acquiring HIV, HCV, STIs and substance use. 

Goals: As part of the AIDS Institute Quality of Care Programs, an overarching goal of the Guidelines Program is to develop and disseminate evidence-based, state-of-the-art clinical practice guidelines that establish a uniform standard of clinical care for all people living with HIV, HCV, STIs and substance use, regardless of the practice or geographic setting in which they receive care. The Guidelines Program also supports New York State’s End-the Epidemic Initiative, including the treatment-as-prevention (TasP) strategy, with strong recommendations for increased testing and linkage to care, immediate initiation of antiretroviral therapy, increased awareness of acute HIV infection, and dedicated efforts to maintain HIV viral load suppression.

Expert committees: AIDS Institute clinical guidelines are developed by committees of expert New York State clinicians. Committee members collaborate to survey and evaluate peer-reviewed literature, write and assess clinical recommendations, and update existing guidelines or create new guidelines as necessary to ensure that recommendations reflect current best practices. All new and revised guidelines undergo peer and consumer review.

Evidence-based recommendations: Committee members apply their expertise and experience in evaluating factors that determine treatment decisions, including potential benefits and outcomes, risks, and burdens to the patient; patient views, values, and preferences; feasibility and tolerability; and the quality of evidence supporting a treatment recommendation. All recommendations are assigned ratings based on the strength and quality of the supporting evidence.

Audience: AIDS Institute clinical care guidelines are produced and disseminated to clinicians in New York who provide prevention services and medical care to people who are living with or at risk of acquiring HIV, HCV, STI and substance use. Guideline recommendations are based on published evidence and the collective expertise of committee members and are practical for use by specialists and low-volume care providers. All involved are committed to publishing guidelines that are used in the real world by busy care providers, who find them to be useful and readily accessible tools with immediate application in daily practice.

The AIDS Institute has always sought to publish guidelines that inform primary care providers who do not specialize in HIV, but who do provide care for people with HIV within New York State. The guidelines are grounded in current research, supported by evidence, and reflect the breadth of experience of committee members who specialize in HIV, HCV, STIs and substance use and who know the realities of providing clinical care throughout the state of New York and in a broad array of clinical settings.

Dissemination and implementation: All clinical care guidelines are published on this HIV Clinical Resource website, where they are freely accessible. The AIDS Institute disseminates the guidelines through multiple channels and numerous programs, and the Clinical Education Initiative provides training to care providers in New York in support of guideline implementation.  

Johns Hopkins Clinical Guidelines Program: The Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases, has collaborated with the New York State Department of Health AIDS Institute since 1999 to develop and disseminate the AIDS Institute’s clinical guidelines and related quality-of-care information. This website is managed by the JHU program.

Funding: The Clinical Guidelines Program is supported by New York State funds allocated through a grant to the JHU School of Medicine to support all activities of the program.

 

Program Leadership and Staff

New York State Department of Health AIDS Institute

The Office of the Medical Director oversees the program.

  • Charles J. Gonzalez, MD, Medical Director
  • Lyn Stevens, MS, NP, ACRN, Deputy Director
  • Laura Duggan Russell, MPH, Program Coordinator

The AIDS Institute OMD consists of public health professionals dedicated to enhancing the quality of life for persons with HIV by improving prevention and health care services through performance measurement and science-based initiatives. The Office of the Medical Director oversees numerous programs and initiatives including:

Johns Hopkins University School of Medicine Clinical Guidelines Program

The Johns Hopkins University School of Medicine, Division of Infectious Diseases, has collaborated with the NYSDOH AIDS Institute since 1999 to develop and disseminate HIV clinical guidelines and related quality-of-care information.

Principal Investigator Christopher J. Hoffmann, MD, MPH provides leadership and strategic to the program and lends extensive experience in both HIV clinical care and guidelines development, as well as a resolute commitment to training for HIV care providers.

The JHU team manages all aspects of guidelines development and dissemination and program administration through the efforts of the following program staff:

  • Mary Beth Hansen, MA, Project Director
  • Jennifer R Ham, MPH, Medical Editor
  • Johanna L Gribble, MA, Medical Editor
  • Jesse M Ciekot, Program Coordinator

Contact Information

JHU: This website is managed and maintained by the staff of the JHU Clinical Guidelines Program. If you have questions about the website or about the JHU Clinical Guidelines program, please send an email to: aiguidelines@jhmi.edu.

Mailing address: JHU Clinical Guidelines Program, 2700 Lighthouse Point East, Suite 260, Baltimore, MD, 21224

NYSDOH AIDS Institute: If you have questions about the NYSDOH AIDS Institute Clinical Guidelines Program, please contact the Guidelines Program Coordinator, Laura Russell: laura.russell@health.ny.gov.

Mailing address: New York State Department of Health AIDS Institute, Office of the Medical Director, 90 Church Street, 13th Floor, New York, New York 10007-2919

Feedback: If you would like to submit feedback on the website and/or its content, please complete our brief survey.

Guideline Development and Committees

Expert Committees

Composition: The Clinical Guidelines Program works directly with committees composed of experts in the field who represent multiple disciplines (medicine, nursing, psychology, pharmacy, public health, social work, mental health), clinical specialties (infectious diseases, family medicine, obstetrics and gynecology, hepatology, pediatrics, psychiatry, dentistry, prevention, etc.), and various geographic regions of New York State.

A Clinical Guidelines Program Steering Committee provides oversight and strategy to the following Clinical Guidelines Program committees, each of which is responsible for developing and updating clinical practice guidelines that fall under its area of expertise. Current committees (May 2018) include the following:

Financial disclosure and confidentiality agreement: All potential and active committee members are required to sign a confidentiality agreement and to disclose annually all financial relationships with commercial entities or gifts that may be actual, potential, or perceived as conflicts of interest. Committee members must report financial relationships with commercial entities that have existed in the 12 months prior to or are expected to exist in the 12 months after the date on which they sign their disclosure form.

Guideline development process: When the Clinical Guidelines Program identifies the need to develop or update a guideline, the committee under whose purview the guideline falls convenes to determine the goals of the guideline and its content, review the published literature, and weigh new evidence for recommendations. Text is then drafted by an author who has experience with the topic of the guideline. The guideline draft is edited by the team at JHU, and then reviewed and modified by the committee. This rigorous development process may entail multiple rounds of review, revision, rating and editing. Decision making occurs by consensus, and all guideline recommendations are reviewed by and receive the consensus approval of the full guideline committee. 

Evidence-based Recommendations: All recommendations are rated to reflect the strength of each recommendation and the quality of the supporting evidence. Ratings are reached through review of the evidence and consensus decision. If the published evidence in support of a particular recommendation is not sufficient, the group relies on collective best practices experience to develop a final statement. The rating scheme for recommendations appears below.

AIDS Institute HIV Clinical Guidelines Program Recommendations Rating Scheme
Strength of Recommendation Quality of Supporting Evidence
A = Strong 1 = At least 1 randomized trial with clinical outcomes and/or validated laboratory endpoints
B = Moderate 2 = One or more well-designed, nonrandomized trial or observational cohort study with long-term clinical outcomes
C = Optional 3 = Expert opinion

External review: All guidelines are reviewed by external experts in the field and by the AIDS Institute’s Consumer Advisory Committee. 

Final approval: The guideline is submitted to the AIDS Institute for review and final approval prior to publication. The AI may request additional review by other agencies and organizations when applicable.

Guideline Updates: Members of guideline committees monitor developments ongoing to maintain guideline currency, at regular intervals. Newly published data that provides support for existing recommendations will be cited in the text and the studies will be added to the reference list. If newly published data prompts a revision to recommendations or rationale, a planning committee proposes appropriate edits and determines whether any changes warrant full committee review and approval. 

Medical Care Criteria Committee (MCCC)

The MCCC is responsible for guidelines that address the care of adults with HIV

Updated August 13, 2018

Leadership

Chair: Joseph P. McGowan, MD, FACP, FIDSA
North Shore University Hospital, Manhasset, NY
No disclosures

Vice-Chair: Steven M. Fine, MD, PhD
University of Rochester Medical Center, Rochester, NY
No disclosures

Chair Emeritus: Samuel T. Merrick, MD
New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY
No disclosures

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health, AIDS Institute, New York, NY
No disclosures

Deputy Medical Director: Lyn C. Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY
No disclosures

JHU Principal Investigator: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD
No disclosures

Contributing Members

James C. M. Brust, MD
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

Elliot DeHaan, MD
New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY
No disclosures

Jack Fuhrer, MD
Stony Brook University School of Medicine, Stony Brook, NY
No disclosures

Christine A. Kerr, MD
Hudson River HealthCare, Beacon, NY
No disclosures

Luz Amarilis Lugo, MD
Mount Sinai Comprehensive Health Program-Downtown, New York, NY
No disclosures

Cynthia H. Miller, MD
Albany Medical Center, Albany, NY
No disclosures

Gene Morse, PharmD, FCCP, BCPS
University at Buffalo School of Pharmacy & Pharmaceutical Sciences, Buffalo, NY
No disclosures

Julie E. Myers, MD, MPH
New York City Department of Health and Mental Hygiene, Queens, NY
No disclosures 

David C. Perlman, MD
Icahn School of Medicine at Mount Sinai, New York, NY
No disclosures

Asa E. Radix, MD, MPH, FACP, AAHIVS
Callen-Lorde Community Health Center, New York, NY
No disclosures

Noga Shalev, MD
Columbia University Medical Center, New York, NY
No disclosures

Antonio E. Urbina, MD 
Mount Sinai Hospital, New York, NY
No disclosures

Rona M. Vail, MD
Callen-Lorde Community Health Center, New York, NY
No disclosures

Agency, Consumer, and Program Liaisons

Sheldon T. Brown, MD, James J. Peters Veterans Affairs Medical Center, Bronx, NY 
New York State Department of Veterans Affairs Medical Center
No disclosures

Douglas G. Fish, MD, NYSDOH, Albany, NY
New York State Department of Health Office of Health Insurance Programs
No disclosures

Annette Gaudino, TAG, New York, NY
Community Liaison, Treatment Action Group 
No disclosures

Peter G. Gordon, MD, Columbia University Medical Center, New York, NY
NYSDOH AIDS Institute HIV Quality of Care Advisory Committee
No disclosures

Carl J. Koenigsmann, MD, NYS DOCCS, Albany, NY 
New York State Department of Corrections and Community Supervision
No disclosures

Carlos Salama, MD, Elmhurst Hospital Center, Elmhurst, NY
New York City Health + Hospitals
No disclosures

Cheryl A. Smith, MD, NYSDOH AIDS Institute, New York, NY 
New York State Department of Health AIDS Institute Clinical Education Initiative
No disclosures

William M. Valenti, MD, FIDSA, Trillium Health, Rochester, NY
Medical Society of the State of New York
Financial disclosure: Scientific Advisor, Gilead Sciences

External Contributors and Reviewers

With gratitude, we acknowledge the efforts of the following external experts who made substantial contributions to or provided peer reviews of clinical guidelines addressing the following topics in adult HIV care. For all guidelines published in 2017 and later, external/peer reviewers are listed in the guideline section “How This Guideline Was Developed.”

Gastrointestinal Complications: Douglas T. Dieterich, MD, Mount Sinai School of Medicine, New York, NY (Peer Reviewer); Michael Poles, MD, New York University Medical Center, New York, NY (Peer Reviewer)

HAV/HIV Co-Infection: Elizabeth Rausch-Phung, MD, MPH, New York State Department of Health, Albany, NY (Peer Reviewer); Daniel Kuhles, MD, New York State Department of Health, Albany, NY (Peer Reviewer)

HIV-2: Grace Y. Minamoto, MD, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY (Contributor); Elizabeth R. Jenny-Avital, MD, Jacobi Medical Center, Bronx, NY (Contributor); Lucia V. Torian, PhD, New York City Department of Health and Mental Hygiene, Long Island City, NY (Contributor); Phyllis Kanki, PhD, Harvard School of Public Health, Boston, MA (Peer Reviewer); Monica M. Parker, PhD, Wadsworth Center, NYSDOH, Albany, NY (Peer Reviewer)

HIV Testing (2016): Monica M. Parker, PhD, New York State Department of Health Wadsworth Center, Albany, NY (Peer Reviewer)

Kidney Disease in HIV-Infected Patients: Jonathan A. Winston, MD, Mount Sinai School of Medicine, New York (Contributor); Andy Choi, MD, University of California, San Francisco, CA (Peer Reviewer); Christina M. Wyatt, MD, Mount Sinai School of Medicine, New York (Peer Reviewer)

Menstrual Disorders in HIV-Infected Women: David C Foster, MD, MPH, University of Rochester School of Medicine and Dentistry, Rochester, NY (Contributor);  John F.J. Clark, MD, Columbia University Medical Center, New York, NY (Peer Reviewer)

Neurologic Complications: David Simpson, MD, Mount Sinai Medical Center, New York, NY (Contributor); Lydia B. Estanislao, MD, Mount Sinai Medical Center, New York, NY (Contributor); Anthony Geraci, MD, Mount Sinai Medical Center, New York, NY (Contributor); David B. Clifford, MD, Washington University School of Medicine, St. Louis, MO (Peer Reviewer) ; Karl Kieburtz, MD, MPH, University of Rochester Medical Center, Rochester, NY (Peer Reviewer) 

Oral Health Complications: Stuart Fischman, DMD, SUNY at Buffalo, Buffalo, NY (Contributor); Georgina Zabos, DDS, MPH, Columbia University School of Dental and Oral Surgery, New York, NY (Peer Reviewer) 

PEP Following Non-Occupational Exposure: Daniel J Egan, MD, FACEP, St Luke’s Roosevelt Hospital Center, New York, NY (Peer Reviewer)

PEP Following Occupational Exposure: Yvette Calderon, MD, MS, Jacobi Medical Center, Bronx, NY (Peer Reviewer); Michela T Catalano, MD, Albert Einstein College of Medicine, Bronx, NY (Peer Reviewer); Daniel J Egan, MD, FACEP, St Luke’s Roosevelt Hospital Center, New York, NY (Peer Reviewer)

PEP for Victims of Sexual Assault: Elizabeth Louise Berberian, MPH, New York State Department of Health AIDS Institute, Albany, NY (Contributor); Mary Chris Schultz, BS, New York State Department of Health AIDS Institute, Albany, NY (Contributor)

Perioperative Management: Sian Jones, MD, Weill Cornell Medical College, NewYork-Presbyterian Hospital, New York, NY (Contributor); Frances R. Wallach, MD, Mount Sinai School of Medicine, New York, NY (Contributor); Michelle S. Cespedes, MD, New York University School of Medicine, New York, NY (Peer Reviewer); Susan A Olender, MD, Columbia Presbyterian Medical Center, New York, NY (Peer Reviewer)

Primary Care Approach to the Patient with HIV Infection: Barbara Chaffee, MD, MPH, United Health Services, Binghamton, NY (Contributor); Kinga Cieloszyk, MD, MPH, New York City Department of Health and Mental Hygiene, New York, NY (Contributor); William M. Valenti, MD, University of Rochester School of Medicine and Dentistry, Rochester, NY (Peer Reviewer) 

Hepatitis C Virus Infection Guidelines Committee

Updated August 13, 2018

Leadership

Co-Chair: Joshua S. Aron, MD
Elmhurst Hospital Center, Elmhurst, NY
No disclosures

Co-Chair: Christine A. Kerr, MD
Hudson River HealthCare, Beacon, NY
No disclosures

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health AIDS Institute, New York, NY
No disclosures

Deputy Medical Director: Lyn C. Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY
No disclosures

JHU Principal Investigator: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD
No disclosures

Contributing Members 

Mary Angerame, MS APN-BC
Jordan Health, Rochester, NY
No disclosures

Ayse Aytaman, MD, AGAF, FACG
Veterans Affairs New York Harbor Healthcare System, Brooklyn, NY
No disclosures

David Bernstein, MD, FAASLD, FACG, AGAF, FACP
Hofstra-Northwell School of Medicine, Manhasset, NY
No disclosures

Kristen Marks, MD
Weill Cornell Medical College, New York, NY
No disclosures

Brianna Norton, DO, MPH
Montefiore Medical Group, Bronx, NY
No disclosures

Ponni V. Perumalswami, MD
Icahn School of Medicine at Mount Sinai, New York, NY
No disclosures

Jeffrey J. Weiss, PhD, MS
Mount Sinai School of Medicine, New York, NY
No disclosures

Agency, Consumer, and Program Liaisons

Paula R. Bozer, MD, Wende Correctional Facility, Alden, NY
New York State Department of Corrections and Community Supervision
No disclosures

Douglas G. Fish, MD, NYSDOH, Albany, NY
New York State Department of Health Office of Health Insurance Programs
No disclosures

Colleen Flanigan, RN, MS, NYSDOH AIDS Institute, Albany, NY
Clinical Liaison, New York State Department of Health AIDS Institute Viral Hepatitis Section
No disclosures

Annette Gaudino, TAG, New York, NY
Community Liaison, Treatment Action Group 
No disclosures

Carl J. Koenigsmann, MD, NYS DOCCS, Albany, NY
New York State Department of Corrections and Community Supervision
No disclosures

Vinh Pham, MD, PhD, Bellevue Hospital Center, New York, NY
New York City Health + Hospitals
No disclosures

Cheryl Santoro, Hudson River HealthCare, Peekskill, NY
Consumer Liaison, Hudson River HealthCare
No disclosures

Jessie Schwartz, RN, MPH, NYC DOHMH, Queens, NY
New York City Department of Health and Mental Hygiene
No disclosures

Cheryl A. Smith, MD, NYSDOH AIDS Institute, New York, NY 
New York State Department of Health AIDS Institute Clinical Education Initiative
No disclosures

William M. Valenti, MD, FIDSA, Trillium Health, Rochester, NY 
Medical Society of the State of New York
Financial disclosure: Scientific Advisor, Gilead Sciences

AIDS Institute HIV Clinical Guidelines Program Committee Reviewers

  • Medical Care Criteria Committee: Samuel T. Merrick, MD (Chair), New York-Presbyterian Hospital, New York, NY; Joseph P. McGowan, MD, FACP, FIDSA (Vice-Chair), Northwell Health, Manhasset, NY; Judith A. Aberg, MD, FIDSA, FACP (Chair Emeritus), Icahn School of Medicine at Mount Sinai, New York, NY
  • Committee for the Prevention of Mother to Child Transmission of HIV: Rodney L. Wright, MD, MS (Co-Chair), Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

EXTERNAL PEER REVIEWERS

  • Douglas T. Dieterich, MD, Icahn School of Medicine at Mount Sinai, New York, NY
  • Ira M. Jacobson, MD, Mount Sinai Beth Israel, New York, NY
  • Oluwaseun Falade-Nwulia, MBBS, MPH, Johns Hopkins University School of Medicine, Baltimore, MD
  • Karla Thorton, MD, University of New Mexico School of Medicine, Albuquerque, NM

*These individuals participated in the early development of the HCV guideline but were no longer in their positions, or were not able to serve as liaisons at the conclusion of the project.

Perinatal Transmission Prevention Guideline Committee

2014-to date; updated July 24, 2018

Leadership

Co-Chair: Rodney L. Wright, MD, MS
Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY

Co-Chair: Murli Purswani, MBChB, FAAP
Bronx-Lebanon Hospital Center, Bronx, NY

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health AIDS Institute, New York, NY

Deputy Medical Director: Lyn Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY

JHU Principal Investigator: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD

Contributing Members and Liaisons

Lan L. Adams, MD, MPH
Women and Children’s Hospital of Buffalo, Buffalo, NY

David A. Baker, MD
Stony Brook School of Medicine, Stony Brook, NY

Keith A. Eddleman, MD
Ichan School of Medicine at Mount Sinai, New York, NY

Gary S. Eglinton, MD
New York Hospital Queens, Flushing, NY

Marc D. Foca, MD
Children’s Hospital of New York, New York, NY

Mahmoud M. Hassanein, MD
Brookdale University Hospital, Brooklyn, NY

Angela D. Kerr, MD
Brooklyn Hospital Center, Brooklyn, NY

Howard L. Minkoff, MD, FACOG
Maimonides Medical Center, Brooklyn, NY

David Rosenthal, DO, PhD
North Shore-LIJ Medical Group, Great Neck, NY

Renee Samelson, MD, MPH
Albany Medical Center, Albany, NY

Roberto P. Santos, MD, MSCS
Albany Medical Center, Albany, NY

Maria Teresa Timoney, CNM
Bronx Lebanon Hospital Center, Bronx, NY

Geoffrey A. Weinberg, MD, FAAP, FIDSA
University of Rochester School of Medicine and Dentistry, Golisano Children’s Hospital, Rochester, NY

Leonard B. Weiner, MD
SUNY Upstate Medical University, Syracuse, NY

Andrew A. Wiznia, MD
Jacobi Medical Center, Bronx, NY

NYSDOH AIDS Institute Liaisons

Lisa M. Haskin, RN, BS, Albany, NY
Prevention of Perinatal Transmission Program

Barbara L. Warren, BSN, MPH, PNP, Albany, NY
Prevention of Perinatal Transmission Program

External Contributors and Reviewers

With gratitude, we acknowledge the efforts of the following external experts who made substantial contributions to or provided peer reviews of clinical guidelines addressing the following topics in pregnancy and HIV infection. 

Acute HIV Infection in Pregnancy: Monica M Parker, PhD, Laboratory of Bloodborne Diseases, Wadsworth Center, New York State Department of Health, Albany, NY (Contributor)

Care of the HIV-Exposed Infant with Indeterminate Status: Murli U Purswani, MBChB, FAAP, Bronx-Lebanon Hospital Center, Bronx, NY(Peer Reviewer); Joseph S Cervia, MD, MBA, FACP, FAAP, FIDSA, AAHIVS, Hofstra North Shore, Long Island Jewish School of Medicine, Hempstead, NY (Peer Reviewer); Roberto P Santos, MD, MSc, Albany Medical Center, Albany, NY (Peer Reviewer)

Diagnosis of Pediatric HIV Infection in HIV-Exposed Infants: Monica M Parker, PhD, Laboratory of Bloodborne Diseases, Wadsworth Center, New York State Department of Health, Albany, NY (Contributor); Roberto Posada, MD, Mount Sinai Hospital, NY (Contributor)

HIV Testing During Pregnancy and at Delivery: Monica M Parker, PhD, Laboratory of Bloodborne Diseases, Wadsworth Center, New York State Department of Health, Albany, NY (Contributor)

Preconception Care for HIV-Infected Women: Katherine D. LaGuardia, MD, MPH, FACOG, Ortho-McNeil Pharmaceutical, Inc., Raritan, NJ (Contributor); Katherine T. Chen, MD, MPH, Columbia University, New York, NY (Peer Reviewer); Roberta A. Stewart, MPH, Bureau of Special Populations, Prevention Division of the AIDS Institute, New York State Department of Health, New York, NY (Peer Reviewer)

 

Sexually Transmitted Infections Guidelines Committee

2016-to date

Leadership

Chair: Marguerite A. Urban, MD
University of Rochester Medical Center, Rochester, NY

Vice-Chair: Michael H. Augenbraun, MD, FACP, FIDSA
SUNY Downstate, Brooklyn, NY  

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health AIDS Institute, New York, NY

Deputy Medical Director: Lyn Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY

JHU Principal Investigator: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD

Contributing Members and Liaisons

Elizabeth Asiago-Reddy, MD
SUNY Upstate, Syracuse, NY

Gale R. Burstein, MD, MPH, FAAP
Erie County Department of Health, Buffalo, NY

Michael M. Gaisa, PhD, MD
Mount Sinai, New York, NY

Shelley Gilroy, MD
Albany Medical College, Albany, NY

Sachin Jain, MD
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

Marla J. Keller, MD
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

Anita P. LaSala, MD
Columbia University Medical Center, New York, NY

Robert Murayama, MD, MPH, AAHIVM, FACP
The Institute for Family Health, New York, NY

Michel Ng, NP
Mount Sinai School of Medicine, New York, NY

Thomas Panzella, PAC
HEAT/Downstate, Brooklyn, NY

Asa Radix, MD, MPH, FACP, AAHIVS
Callen-Lorde Community Health Center, New York, NY

David W. Rosenthal, DO, PhD
Northwell Health Physician Partners, Great Neck, NY 

Heather M. Territo, MD
University at Buffalo-SUNY, Buffalo, NY

Agency, Consumer, and Program Liaisons

Bisrat K. Abraham, MD, NYC DOHMH, Long Island City, NY
New York City Department of Health and Mental Hygiene

Beatrice Aladin, MD, MPH, NYSDOH AI, New York, NY
New York State Department of Health AIDS Institute Clinical Education Initiative

Richard Greene, MD, FACP, FIDSA, New York, NY
New York City Health + Hospitals

David Martin, New York, NY
New York State Department of Health AIDS Institute Consumer Advisory Committee

Tarek Mikati, MD, MPH, NYC DOHMH, Long Island City, NY 
New York City Department of Health and Mental Hygiene

External Contributors and Reviewers

With gratitude, we acknowledge the efforts of the following external experts who made substantial contributions to or provided peer reviews of clinical guidelines addressing the following topics in the care of adults with STIs and HIV infection. 

Bacterial Vaginosis: Carola Marte, MD, Community Health Center, Inc, Meriden, NY (Contributor); Susan Blank, MD, MPH, and Kristen Harvey, MD, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer); F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Chancroid: Carola Marte, MD, Community Health Center, Inc, Meriden, NY (Contributor); Susan Blank, MD, MPH, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer); Kristen Harvey, MD, Bureau of STD Control, NYC DOHMH, New York, NY (Peer Reviewer); F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Genital Herpes Simplex Virus (HSV): Barry S. Zingman, MD, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY (Contributor); Susan Blank, MD, MPH, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer); F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Gonococcal and Chlamydial Infections: Douglas G. Fish, MD, Albany Medical College, Albany, NY (Contributor); Jessica E. Justman, MD, Columbia University, New York, NY (Contributor); Susan Blank, MD, MPH, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer); F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Human Papillomavirus (HPV): Gina M. Brown, MD, New York City Department of Health, New York, NY (Contributor); Susan Blank, MD, MPH, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer); F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Lymphogranuloma Venereum (LGV): F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Syphilis: Barry S Zingman, MD, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY (Contributor); Judith A Aberg, MD, New York University School of Medicine, New York, NY (Contributor); Eunmee H. Chun, MD, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer)

Trichomoniasis: Carola Marte, MD, Community Health Center, Inc, Meriden, NY (Contributor); Gina M Brown, MD, National Institutes of Health, Office of AIDS Research, Bethesda, MD (Contributor); Eunmee H. Chun, MD, MPH, Bureau of STD Prevention and Control, New York City Department of Health and Mental Hygiene, Long Island City, NY (Peer Reviewer); Demetre C Daskalakis, MD, Bellevue Hospital, NYU Langone Medical Center, New York, NY (Peer Reviewer)

Substance Use Guidelines Committee

2016-to date; updated August 13, 2018

Leadership

Chair: Chinazo O. Cunningham, MD, MS
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

Vice-Chair: Kelly S. Ramsey, MD, MPH, MA, FACP
Hudson River HealthCare, Poughkeepsie, NY
No disclosures

Consulting Expert: Sharon L. Stancliff, MD
Harm Reduction Coalition Liaison, New York, NY
No disclosures

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health AIDS Institute, New York, NY
No disclosures

Deputy Medical Director: Lyn C. Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY
No disclosures

JHU Principal Investigator: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD
No disclosures

Contributing Members

Marcus Bachhuber, MD, MS
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

Michael L. Christie, MD
University of Rochester Medical Center, Rochester, NY
No disclosures

Angela G. Giovanniello, PharmD, AAHIVP
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

Raymond Harvey, MD
Institute for Family Health, Kingston, NY
No disclosures

Giliane Joseph, MD
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

Shadi Nahvi, MD, MS
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

David C. Perlman, MD
Icahn School of Medicine at Mount Sinai, New York, NY
No disclosures

Paul Updike, MD
St. Vincent’s/Sisters Hospital, Buffalo, NY
No disclosures

Susan D. Whitley, MD
New York City Health + Hospitals/Kings County, Brooklyn, NY
No disclosures

Timothy J. Wiegand, MD
University of Rochester Medical Center, Rochester, NY
No disclosures

Agency, Consumer, and Program Liaisons

Hillary Kunins, MD, MPH, MS, NYC DOHMH, Queens, NY
New York City Department of Health and Mental Hygiene
No disclosures

Allan Clear, NYSDOH AIDS Institute, New York, NY
New York State Department of Health AIDS Institute
No disclosures

Annette Gaudino, TAG, New York, NY
Community Liaison, Treatment Action Group
No disclosures

External Contributors and Peer Reviewers

With gratitude, we acknowledge the efforts of the following external experts who made substantial contributions to or provided peer reviews of clinical guidelines addressing the following topics in substance use and HIV care prior to 2016.

Adherence to Antiretroviral Therapy Among Substance Users: Julia H Arnsten, MD, MPH, Montefiore Medical Center, Bronx, NY (Contributor); David Bangsberg, MD, MPH, University of California, San Francisco, CA (Peer Reviewer); Lois Eldred, DrPH, Health Resources and Services Administration, HIV/AIDS Bureau, Rockville, MD (Peer Reviewer)

Aspects of Primary Care for the HIV-Infected Substance User: David C Perlman, MD, Beth Israel Medical Center, and National Development and Research Institutes, New York, and Albert Einstein College of Medicine, Bronx, NY (Contributor); Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY (Contributor); Vladimir Poznyak, MD, PhD, World Health Organization (Peer Reviewer); Jeffrey Samet, MD, MA, MPH, Boston University School of Medicine, Boston, MA (Peer Reviewer)

Care of the Hospitalized HIV-Infected Substance User: Brenda Chabon, PhD, Montefiore Medical Center, Bronx, NY (Contributor); Eunmee H. Chun, MD, New York State Department of Health AIDS Institute, New York, NY (Contributor); Barbara Chaffee, MD, MPH, United Health Services, Binghamton, NY (Contributor); Sheree Starrett, MD, Casa Promesa, Bronx, NY (Peer Reviewer); Stanley R. Yancovitz MD, Beth Israel Medical Center, New York, NY (Peer Reviewer)

Clinical Management of Alcohol Use and Abuse in HIV-Infected Patients: Joseph Conigliaro, MD, MPH, VA Pittsburgh Healthcare System, and the University of Pittsburgh School of Medicine, Pittsburgh, PA (Contributor); Thomas Kresina, PhD, National Institute on Drug Abuse, Bethesda, MD (Peer Reviewer); Richard Saitz, MD, MPH, Boston University School of Medicine, Boston, MA (Peer Reviewer)

Drug-Drug Interactions Between ARV Agents, Medications Used in Substance Use Treatment, and Recreational Drugs: John J. Faragon, PharmD, Albany Medical Center, Albany, NY (Contributor); Paul Pham, PharmD, The Johns Hopkins University, Baltimore, MD (Contributor); Elinore F. McCance-Katz, MD, PhD, Virginia Commonwealth University, Richmond, VA (Peer Reviewer)

Medical Care of HIV-Infected Substance-Using Women: Diane M. Rudnick, MEd, New York State Department of Health AIDS Institute, New York, NY (Contributor); Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY (Contributor); Hillary Kunins, MD, MPH, Montefiore Medical Center, Bronx, NY (Peer Reviewer); Barbara C. Zeller, MD, Project Samaritan AIDS Services, Bronx, NY (Peer Reviewer)

Mental Health Disorders Among Substance-Using HIV-Infected Patients: Steven L Batki, MD, SUNY Upstate Medical University, Syracuse, NY (Contributor); John AR Grimaldi, Jr, MD, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY (Contributor); Marshall Forstein, MD, The Cambridge Hospital, Cambridge, MA (Peer Reviewer); George E. Woody, MD, University of Pennsylvania, and the Philadelphia VA Medical Center, Philadelphia, PA (Peer Reviewer)

Pain in the HIV-Infected Substance User: Robert B. Whitney, MD, Erie County Medical Center, Buffalo, NY; William S. Breitbart, MD, Memorial Sloan-Kettering Cancer Center, New York, NY (Peer Reviewer); Andrew Rosenblum, PhD, National Development and Research Institutes, New York, NY (Peer Reviewer)

Screening and Ongoing Assessment for Substance Use; Barbara Chaffee, MD, MPH, United Health Services, Binghamton, NY (Contributor); Thomas F. Babor, PhD, MPH, The Alcohol Research Center at the University of Connecticut School of Medicine, Farmington, CT (Peer Reviewer); Joseph Conigliaro, MD, MPH, VA Pittsburgh Healthcare System, and the University of Pittsburgh School of Medicine, Pittsburgh, PA (Peer Reviewer)

Smoking Cessation in HIV-Infected Patients: Julia H Arnsten, MD, MPH, Montefiore Medical Center, Bronx, NY (Contributor); Alvaro Carrascal, MD, MPH, New York State Department of Health, Albany, NY (Peer Reviewer); Kimber P. Richter, PhD, MPH, University of Kansas Medical Center, Kansas City, KS (Peer Reviewer)

Substance Use Treatment Modalities for HIV-Infected Substance Users: Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY (Contributor); Marc N. Gourevitch, MD, MPH, New York University School of Medicine, New York, NY (Contributor); Jeffrey Rothman, New York State Department of Health AIDS Institute, New York (Contributor); Deborah Brotman, MD, Center For Comprehensive Health Practice, New York, NY (Peer Reviewer)

What Are These Drugs? Steven S Kipnis, MD, FACP, FASAM, New York State Office of Alcoholism and Substance Abuse Services, Orangeburg, and Albany Medical College, Albany, NY (Contributor); Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY (Contributor)

Working With the Active User: Nancy Murphy, NP, St Luke’s Roosevelt Hospital Center, and CUNY Graduate Center, New York, NY (Contributor); Robert B. Whitney, MD, Erie County Medical Center, Buffalo (Contributor); Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY (Contributor); Kumara Singaravelu, MBBS, MPH, New York County Health Services Review Organization, New York, NY (Peer Reviewer)

Dental Standards of Care Committee

2012-to date

Leadership

Chair: Stephen N. Abel, DDS, MSD
University at Buffalo-SUNY, Buffalo, NY

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health, AIDS Institute, New York, NY

Deputy Medical Director: Lyn C. Stevens, MS, NP, ACRN
Office of the Medical Director, New York State Department of Health AIDS Institute, Albany, NY

JHU Principal Investigator: Christopher J. Hoffmann, MD
Johns Hopkins University School of Medicine, Baltimore, MD

Contributing Members

Victor M. Badner, DMD, MPH
North Bronx Healthcare Network, Bronx, NY

Mary Therese Biltucci, RDH, MA
University of Rochester, Rochester, NY

Stanley J. Boyd, DMD
Healthy Chelsea Dentistry, New York, NY

Gwen Cohen Brown, DDS, FAAOMP
New York City College of Technology, Brooklyn, NY

Dolores Cottrell-Carson, DDS, MSHA
New York State Board for Dentistry, Albany, NY

Maria de los Angeles Figueroa, DMD
Bronx-Lebanon Hospital Center, Bronx, NY

Mary J. D’Silva, DDS
NYS DOC and Community Supervision, Albany, NY

Robert D. Kelsch, DMD
Northwell Health, Manhasset, NY

Michael A. Kozlowski, DDS
Unity Dental Group, Rochester, NY

Kareem J. Merrick, DDS
Harlem United Community Clinic, New York, NY

Calix Ramos-Rodriguez, DMD
Lutheran Medical Center, Brooklyn, NY

Miriam R. Robbins, DDS, MS
Winthrop University Hospital, Mineola, NY

Dara J. Rosenberg, DDS, MS, MPH
St. Barnabas Hospital, Bronx, NY

Terrence T. Thines, DDS, MS
SUNY Upstate Medical University, Syracuse, NY

Agency, Consumer, and Program Liaisons

Britta Viereckl-Prast, DMD
New York State Department of Corrections and Community Supervision, Bedford Hills, NY

Jahlove Serrano
New York State Department of Health AIDS Institute Consumer Advisory Committee, Bronx, NY

David Martin
New York State Department of Health AIDS Institute Consumer Advisory Committee, New York, NY

External Contributors and Reviewers

With gratitude, we acknowledge the efforts of the following external experts who made substantial contributions to or provided peer reviews of clinical guidelines addressing the following topics in oral health care for adults with HIV infection

Clinical Manifestations and Management of HIV-Related Periodontal Disease: Barbara Gerbert, PhD, University of California School of Dentistry, San Francisco, CA (Peer Reviewer)

Diagnosis and Management of Soft-Tissue Lesions: Stuart L Fischman, DMD, State University of New York, Buffalo, NY (Contributor); Michael Glick, DMD, University of Pennsylvania School of Dental Medicine, Philadelphia, PA (Peer Reviewer)

General Principles: Georgina P. Zabos, DDS, MPH, Columbia University School of Dental and Oral Surgery, New York, NY (Contributor); Amneris E. Luque, MD, Strong Memorial Hospital, Rochester, NY (Peer Reviewer); Barbara H. Chaffee, MD, MPH, Binghamton Family Care Center, United Health Services Hospital, Binghamton, NY (Peer Reviewer); Marc N. Gourevitch, MD, MPH, New York University School of Medicine, New York, NY (Peer Reviewer)

HIV Testing in the Oral Healthcare Setting: Joan A. Phelan, DDS, New York University College of Dentistry, New York, NY (Peer Reviewer); Michael Hatton, DDS, University at Buffalo, Buffalo, NY (Peer Reviewer)

Infection Control: Helene Bednarsh, RDH, MPH, HIV Dental at Boston Public Health Commission, Boston, MA (Peer Reviewer)

Oral and Maxillofacial Surgery: David Drohan, DDS, Albany Medical College, Division of Dentistry, Albany, NY (Contributor); Paul E Gates, DDS, MBA, Bronx-Lebanon Hospital Center, Bronx, NY (Contributor); Robert S Glickman, DMD, New York University College of Dentistry, New York, NY (Peer Reviewer)

About this Website

Purpose

The NYSDOH AI Clinical Guidelines website publishes the clinical practice guidelines and related materials produced by the Clinical Guidelines Program. The program is a collaborative effort of the New York State Department (NYSDOH) of Health AIDS Institute’s (AI) Office of the Medical Director (OMD) and the Johns Hopkins University School of Medicine, Division of Infectious Diseases. This website is maintained and managed by the JHU Clinical Guidelines program, within the Johns Hopkins University School of Medicine, Division of Infectious Diseases. 

Production and Development 

  • WordPress development and programming: Alexei Yukna
  • Graphic design: Laura Hatcher, Hatcher Design Office
  • Managing Editor: Mary Beth Hansen
  • Website production: Johanna Gribble and Jesse Ciekot

Editorial Policies & Procedures

This website is produced and maintained by the JHU Clinical Guidelines Program in the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases. The site does not does not purport to advance any official positions of JHU, the JHU School of Medicine, or the Division of Infectious Diseases. The JHU Clinical Guidelines Program, in collaboration with the NYSDOH AI maintains editorial control of all materials published on this site, and unless noted otherwise, all materials posted on this site have been produced under the auspices NYSDOH AIDS Institute Clinical Guidelines Program.

Mention of specific products by generic or brand name does not constitute endorsement by the Clinical Guidelines Program, or its committee members, editors, or staff; NYSDOH or the AI or its staff. Any mention of specific products is for the informational purposes only. Regarding specific products or drugs, physicians and other health care providers are advised to consult their normal resources before prescribing to their patients.

The JHU Clinical Guidelines Program does not provide clinical care and does not provide clinical or medical advice. 

Contact Us 

We will make every effort to answer e-mail submitted to any of the above addresses within 48 hours.

Privacy

This website is designed to provide public access to the clinical practice guidelines published by the JHU Clinical Guidelines Program on behalf of and under the direction of the New York State Department of Health AIDS Institute Clinical Guidelines Program.

The JHU Clinical Guidelines Program recognizes the importance of protecting the privacy of visitors to the HIV Clinical resource website and of subscribers to the site mailing list and to the monthly Topic, Trends, and Updates e-mail update.

Stored information: Most information transmitted over the Internet is not secure; thus, confidentiality cannot be guaranteed. However, of the information transmitted via your visit to the Clinical Guidelines Program website, we store the following: the IP address from which you access the Internet, the date and time, the Internet address of the Web site from which you linked directly to our site, the name of the file or the words you searched, and the browser used to access our site. This information is used to measure the number of visitors to the various sections of our site and identify system performance or problem areas. We also use this information to help us improve features of the site and to make the site more useful.

Personally provided information: If you choose to provide us with personal information by sending an email, or by subscribing to one or both of our mailing lists and submitting that information it through our Web site, we will use that information to respond to your message, to send you email that you have asked to receive, and to help us provide you with information or material that you may request. We do not give, share, sell, or transfer any of your personal information to a third party unless required by law.

If you submit a question that would be best answered by a staff member of the NYSDOH AIDS Institute, we may forward your question to that staff member. When we do, we may or may not include your email address so the staff member may respond to you directly. Submitting a question through this website constitutes your tacit agreement with the actions the JHU website managers may take to secure the best answer possible in a timely manner.

Links to other sites: For the convenience of those who access and use the content published on this site (ie, the site users), many pages contain links to Web pages and Web sites that are not managed by the JHU Clinical Guidelines program. Neither the JHU Clinical Guidelines Program, nor The Johns Hopkins University nor The Johns Hopkins School of Medicine, nor the NYSDOH AIDS Institute Clinical Guidelines Program control or take responsibility for the content of those Web sites. Links from this Web site to Web sites not managed by any of the entities named above do not imply endorsement or credibility of the service, information, or product offered through the linked sites. Links are provided to make it easy for users to access supplementary content. 

Some of the pages on this site provide links to other Web sites that provide health information. Once a user links to another site, she or he is subject to the privacy policy of that other site.

Disclaimer: The information provided in this privacy statement should not be construed as giving business, legal, or other advice, or warranting as fail proof, the security of information provided through this website.

Terms of Use

While every possible effort if made to post accurate and reliable information on this website, neither the JHU Clinical Guidelines Program, neither the JHU Clinical Guidelines Program, nor The Johns Hopkins University nor The Johns Hopkins School of Medicine, nor the NYSDOH AIDS Institute HIV Clinical Guidelines Program assumes responsibility for the use or application of information posted on any page of this website or guarantees or warrants that the information posted on any page of this site is complete and without any error or inaccuracy. The website, its editors, advisers, staff, authors, and sponsoring institutions assume no responsibility for any error, omissions, or other discrepancies between the electronic documents published on this site and source materials.

Physicians and other healthcare professionals are encouraged to consult other sources and confirm the information contained in this site because no single reference or service can take the place of medical training, education, and experience.

Consumers are cautioned that this site is not intended to provide medical advice about any specific medical condition or treatment and are encouraged to call or see their physician or other health care provider promptly with any health-related questions or concerns they may have.

This website links to websites maintained by other entities. Reasonable precautions are taken to link only to websites that publish appropriate and accurate material and are maintained by reputable organizations. However, those web pages are not under the direction or control of this website, and this website can therefore not be held responsible for the information or opinions expressed in those linked sites.

The use, reproduction, and distribution of original documents and related graphics from this web site is encouraged provided that full credit of source accompanies all uses, in all forms. Please note that if we have adapted or reproduced copyrighted material from another source, with permission, we cannot extend permission to reproduce. Links to pages on this site are also encouraged and may be created without seeking permission.

Any use of materials from this site should be accompanied by the following citation of source: 

This material was accessed on [dd/mo/year] on the HIV Clinical Resource website (www.hivguidelines.org). The HIV Clinical Guidelines Program is a collaborative effort of the New York State Department of Health AIDS Institute and the Johns Hopkins University Division of Infectious Diseases. Copyright © Johns Hopkins University HIV Clinical Guidelines Program 2000-2016. 

Requests to adapt material, i.e., to change or alter in any way material from this site for the purpose of inclusion in another publication, should be sent to aiguidelines@jhmi.edu. Please include detailed information about the intended use and desired adaptations.

The names of the New York State Department of Health, the Johns Hopkins University Division of Infectious Diseases, Clinical Guidelines Program, or its staff may not be used in publicity or advertising without express written permission. Exceptions to this include listings on web indexes, search engines, and related systems.

Contact Us

Mailing address:

JHU Clinical Guidelines Program
2700 Lighthouse Point East, Suite 260
Baltimore, MD, 21224

E-mail addresses:

We will make every effort to answer e-mail submitted to any of the above addresses within 48 hours.

Sign Up for Topics, Trends & Updates

Sign Up for the Monthly Topics, Trends & Updates E-Mail

Topics, Trends & Updates subscribers receive a monthly email with notification of new guidelines or updates and other highlights from the Clinical Guidelines Program, including hot topics, events, What We’re Reading, trends in guideline use, and more. 

Visit the Topics, Trends & Updates archive to see previous issues.

Privacy: We do not sell, rent, or share our email lists with anyone. 

Address


By submitting this form, you are consenting to receive marketing emails from: HIV Clinical Guidelines Program at JHU, 2700 Lighthouse Point East, , Baltimore, MD, 21224, http://www.hivguidelines.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact